Cargando…
Prioritization for interferon-free regimens and potential drug interactions of current direct-acting anti-hepatitis C agents in routine clinical practice
BACKGROUND: We determined the proportions of patients with chronic hepatitis C (CHC) in association with possible prioritized indications for interferon-free regimens and the use of co-medications with potential drug-drug interactions (DDIs). METHODS: Five hundred consecutive mono-infected CHC patie...
Autores principales: | Papatheodoridi, Μargarita, Dalekos, George N., Goulis, John, Manolakopoulos, Spilios, Triantos, Christos, Zachou, Kalliopi, Koukoufiki, Argyro, Κourikou, Αnastasia, Ζisimopoulos, Κonstantinos, Τsoulas, Christos, Papatheodoridis, George V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566775/ https://www.ncbi.nlm.nih.gov/pubmed/28845110 http://dx.doi.org/10.20524/aog.2017.0170 |
Ejemplares similares
-
Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
por: Siakavellas, Spyros, et al.
Publicado: (2021) -
The Impact of Host Metabolic Factors on Treatment Outcome in Chronic Hepatitis C
por: Savvoula, Savvidou, et al.
Publicado: (2012) -
The role of vitamin D receptor polymorphisms in the course of chronic hepatitis C infection
por: Tsounis, Efthymios P., et al.
Publicado: (2022) -
Aiming towards hepatitis C virus elimination in Greece
por: Papatheodoridis, George V., et al.
Publicado: (2019) -
Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis
por: Kranidioti, Hariklia, et al.
Publicado: (2018)